- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Sunquest posts loss despite strong growth
Sunquest posts loss despite strong growthTucson, AZ-based Sunquest Information Systems reported a 25% increase in revenue for its third quarter. Despite healthy revenue growth, however, earnings before write-offs were below analysts'
Sunquest posts loss despite strong growth
Tucson, AZ-based Sunquest Information Systems reported a 25% increase in revenue for its third quarter. Despite healthy revenue growth, however, earnings before write-offs were below analysts' expectations.
For the third quarter (end-September), Sunquest had revenues of $24.3 million, compared with $19.3 million for the same period in 1996. The company reported a net loss after write-offs of $268,000, compared with a net income of $1.7 million for the third quarter in 1996.
Sunquest had two sizable write-offs in the quarter: $1.3 million for in-process technology acquired in connection with the purchase of the PreciseCare Medication Management System from Medintell Systems and $1.5 million for previously capitalized software development costs relating to Sunquest's IntelliCarer suite of products.
The primary reason the company failed to meet analysts' expectations for earnings before write-offs was delays in customer installation schedules and the resultant delays in revenue recognition, said Dr. Sidney Goldblatt, president and CEO. The company is taking steps to mitigate these delays by increasing staff in certain areas such as interfacing, customer training, and targeted consulting.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
